---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-055694"
form_type: "8-K"
ticker: "SEER"
cik: "0001726445"
company_name: "Seer, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T11:49:55.966855+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Seer Q1 revenue down 24% YoY to $3.1M; net loss narrows to $20.7M; authorizes $25M buyback

## Summary
- Revenue $3.1M (-24% YoY); product revenue $2.5M (incl. $828K related party), service $534K.
- Net loss $20.7M improved from $24.0M; gross margin 44%; operating expenses $26.6M (-10% YoY).
- Cash and investments $359.2M; board authorized up to $25M share repurchase program.
- FY2024 revenue guidance of $16M-$18M, essentially flat vs FY2023 revenue.
- Expanding Proteograph STAC program to Europe; three new peer-reviewed publications supporting platform.

## SEC filing metadata
- accession: 0000950170-24-055694
- form_type: 8-K
- ticker: SEER
- cik: 0001726445
- company_name: Seer, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726445/000095017024055694/0000950170-24-055694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726445/000095017024055694/ck0001726445-20240508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-055694
- JSON: https://secwatch.observer/filing/0000950170-24-055694.json
- Plain text: https://secwatch.observer/filing/0000950170-24-055694.txt

## Key facts
- Earnings Releases
  Seer, Inc. reported the first quarter ended March 31, 2024 results: revenue $3.1 million. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $3.1 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights • Achieved revenue of $3.1 million for the first quarter of 2024 • Announced the expansion of the Seer Technology Access Center (STAC) program to Europe, providing researchers with end-to-end services from sample
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726445/000095017024055694/0000950170-24-055694-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.